Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.40

-0.05 (-3.45%)

As of Jun 30, 10:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +2,485.7% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $1.40

Current
$1.40

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

1,667.9%

Low target

Base Case

$36.20

+2,485.7%

Avg target

Bull Case

$54.95

+3,825.0%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.62

-46.5% from high

52-Week Low

$0.72

+94.4% from low

Target vs 52W High

$36.20

+1,283.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%